Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
2.925
-0.115 (-3.78%)
Aug 14, 2026, 11:16 AM EDT - Market open

Apyx Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
123146609181441
Market Cap Growth
45.47%144.92%-34.21%12.12%-81.65%78.68%
Enterprise Value
135.23154.1466.8685.8471.77410.88
Last Close Price
2.933.501.582.622.3412.82
Forward PE
-267.00267.00267.00267.00267.00
PEG Ratio
-20.6320.6320.6320.6320.63
PS Ratio
2.192.771.241.731.829.09
PB Ratio
12.0110.064.203.402.158.21
P/TBV Ratio
11.699.893.953.402.158.20
EV/Sales Ratio
2.402.921.391.641.618.47
Debt / Equity Ratio
3.532.622.681.420.010.00
Net Debt / Equity Ratio
1.130.520.49-0.19-0.25-0.57
Net Debt / EBITDA Ratio
-4.36-1.31-0.380.310.412.26
Net Debt / FCF Ratio
-1.09-0.83-0.370.890.442.74
Asset Turnover
0.910.800.670.800.740.68
Inventory Turnover
2.202.452.141.711.662.75
Quick Ratio
4.414.154.404.532.403.94
Current Ratio
5.685.005.265.523.634.60
Return on Equity (ROE)
-64.89%-76.15%-114.21%-58.26%-50.71%-25.79%
Return on Assets (ROA)
-5.84%-10.03%-26.44%-23.34%-39.73%-20.75%
Return on Invested Capital (ROIC)
-16.77%-30.18%-88.33%-60.94%-92.36%-64.34%
Return on Capital Employed (ROCE)
-6.62%-11.80%-31.25%-32.43%-49.38%-23.99%
Buyback Yield / Dilution
-10.48%-15.62%-2.66%-0.31%-0.54%-0.35%
Total Shareholder Return
-10.48%-15.62%-2.66%-0.31%-0.54%-0.35%
SEC Filings: 10-K · 10-Q